Cumberland Pharmaceuticals (CPIX) Profit After Tax Growth (3y) (2013 - 2026)
Cumberland Pharmaceuticals (CPIX) Profit After Tax Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.64 Bn | 87.78 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.90 Bn | 32.16 Bn | 1.97 Bn | 51.23% |
| 3 | Zoetis | 32.50 Bn | 30.56 Bn | 1.62 Bn | 2.94% |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -70.53% |
| 5 | United Therapeutics | 22.98 Bn | 20.83 Bn | 648.10 Mn | 4.50% |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.38 Bn | 18.57 Bn | 1.16 Bn | -7.75% |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn | 66.11% |
| 9 | Elanco Animal Health | 12.67 Bn | 12.24 Bn | 785.00 Mn | -17.90% |
| 10 | Cumberland Pharmaceuticals | 103.45 Mn | 92.44 Mn | 7.20 Mn | -176.30% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -176.30% |
| Dec 31, 2025 | 16.35% |
| Sep 30, 2025 | -66.37% |
| Jun 30, 2025 | 18.43% |
| Mar 31, 2025 | 42.54% |
| Dec 31, 2024 | 20.94% |
| Sep 30, 2024 | -13.35% |
| Jun 30, 2024 | -51.80% |
| Mar 31, 2024 | -75.70% |
| Dec 31, 2023 | -92.48% |
| Sep 30, 2023 | -29.63% |
| Jun 30, 2023 | 43.42% |
| Mar 31, 2023 | 27.88% |
| Dec 31, 2022 | -36.45% |
| Sep 30, 2022 | 49.65% |
| Jun 30, 2022 | -35.42% |
| Mar 31, 2022 | -166.76% |
| Dec 31, 2021 | -20.12% |
| Sep 30, 2021 | 13.72% |
| Jun 30, 2021 | 44.31% |